Lifevantage CORP 8-K filings

LifeVantage Corporation has adopted the 2026 New Employee Long-Term Incentive Plan to attract and retain key personnel.

LifeVantage Corporation reported a 25.2% decrease in third-quarter fiscal 2026 revenue to $43.7 million, primarily due to lower sales of its MindBody GLP-1 System.

LifeVantage Corporation has named industry veteran Terrence Moorehead as its new President and CEO, effective August 5, 2026.

LifeVantage Corporation announced the resignations of its Chief Marketing Officer, Julie Boyster, and Chief Information and Innovation Officer, Todd Thompson.

LifeVantage Corporation announced the results of its fiscal year 2026 annual meeting, where stockholders elected directors and approved key proposals.

LifeVantage reported a 0.7% revenue increase to $47.6 million for Q1 FY2026, with net income per diluted share rising to $0.17, as its LoveBiome acquisition integration progresses positively.

LifeVantage Corporation reported robust financial results for its fourth fiscal quarter and full fiscal year 2025, driven by strong revenue growth in the Americas and a return to international expansion.

LifeVantage Corporation announced a 21.1% increase in revenue for the third quarter of fiscal year 2025, driven by strong demand for its MindBody GLP-1 System.

LifeVantage Corporation announces a 31.3% increase in revenue for the second quarter of fiscal 2025, driven by the success of its MindBody GLP-1 System.

LifeVantage Corporation has eliminated its Series A Junior Participating Preferred Stock after the expiration of its associated Rights Agreement.

LifeVantage Corporation successfully held its annual meeting, electing eight directors and approving several key proposals including executive compensation and amendments to incentive plans.

LifeVantage Corporation reported a decrease in revenue for the first quarter of fiscal year 2025, but saw improvements in net income and adjusted EBITDA.

LifeVantage Corporation reported a decrease in revenue for both the fourth quarter and full fiscal year 2024, but saw improvements in adjusted EBITDA and earnings per share.

LifeVantage Corporation has appointed Rajendran Anbalagan to its Board of Directors, effective immediately, following the resignation of Erin Brockovich.

LifeVantage Corporation reported a decrease in revenue for the third quarter of fiscal year 2024, but saw significant improvements in profitability and adjusted EBITDA.

LifeVantage Corporation has entered into a loan agreement with Bank of America for a $5 million revolving line of credit, secured by substantially all of the company's assets.

LifeVantage Corporation has entered into a cooperation agreement with the Radoff-Sudbury Group, resulting in the appointment of Dayton Judd to the Board of Directors and the withdrawal of a shareholder demand.

LifeVantage Corporation announced a decrease in revenue but a significant improvement in profitability for the second quarter of fiscal year 2024, driven by its LV360 initiatives and strong sales of its TrueScience Liquid Collagen product.